Pure Global AI
NCT06032819Not yet recruiting

Differentiating Between Brain Hemorrhage and Contrast

Artificial Intelligence for Differentiating Between Brain Hemorrhage and Contrast Extravasation After Mechanical Revascularization in Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityClinicalTrials.gov
Study focus
Disease/Condition
Ischemic Stroke
Study type
Observational
Sponsor & location
Primary sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Dec 01, 2024
Enrollment
500 participants
Primary outcome

Develop a deep learning model to differentiate brain hemorrhage from contrast agent extravasation, and evaluate the model performance and generalization ability

Summary

The goal of this observational study is to use artificial intelligence to differentiate
 cerebral hemorrhage from contrast agent extravasation after mechanical revascularization in
 ischemic stroke.
 
 The main question it aims to answer is: Whether artificial intelligence can help
 differentiate brain hemorrhage from contrast agent extravasation.
 
 Patients with intracranial high-density lesions on CT scans within 24h after mechanical
 revascularization will be included. Expected to enroll 500 patients. The type of high-density
 lesion is determined according to dual-energy CT images or follow-up images. Patients will be
 divided into training group, validation and testing groups by stratified random sampling
 (6:2:2). After the images and the image labels are obtained, deep learning artificial
 intelligence will be used to learn the image characteristics and establish a diagnostic
 model, and the model performance and generalization ability will be evaluated.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06032819
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06032819 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.